Trademark: 87900878
Word
ARINGAGE
Status
Registered
Status Code
700
Status Date
Tuesday, January 28, 2020
Serial Number
87900878
Registration Number
5970134
Registration Date
Tuesday, January 28, 2020
Mark Type
4000
Filing Date
Monday, April 30, 2018
Published for Opposition
Tuesday, November 12, 2019

Trademark Owner History
CMG Pharmaceutical Co.,Ltd. - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; drugs for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; multivitamins preparations; pharmaceutical preparations for diagnosis for medical orveterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease; antibiotics

Trademark Events
Jan 28, 2020
Registered-Principal Register
Nov 12, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 12, 2019
Published For Opposition
Oct 23, 2019
Notification Of Notice Of Publication E-Mailed
Oct 5, 2019
Approved For Pub - Principal Register
Sep 26, 2019
Teas/Email Correspondence Entered
Sep 25, 2019
Correspondence Received In Law Office
Sep 25, 2019
Teas Response To Office Action Received
Jul 11, 2019
Notification Of Priority Action E-Mailed
Jul 11, 2019
Priority Action E-Mailed
Jul 11, 2019
Priority Action Written
Jul 1, 2019
Previous Allowance Count Withdrawn
Mar 26, 2019
Withdrawn From Pub - Og Review Query
Mar 12, 2019
Electronic Record Review Complete
Mar 8, 2019
On Hold - Electronic Record Review Required
Mar 6, 2019
Approved For Pub - Principal Register
Feb 25, 2019
Teas/Email Correspondence Entered
Feb 25, 2019
Correspondence Received In Law Office
Feb 13, 2019
Assigned To Lie
Feb 7, 2019
Teas Response To Office Action Received
Aug 21, 2018
Notification Of Non-Final Action E-Mailed
Aug 21, 2018
Non-Final Action E-Mailed
Aug 21, 2018
Non-Final Action Written
Aug 21, 2018
Assigned To Examiner
May 9, 2018
New Application Office Supplied Data Entered In Tram
May 3, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24